These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1340278)

  • 1. The killing of Entamoeba histolytica by activated human eosinophils.
    López-Osuna M; Arellano J; Giménez-Scherer JA; Kretschmer RR
    Arch Med Res; 1992; 23(2):143-5. PubMed ID: 1340278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The destruction of virulent Entamoeba histolytica by activated human eosinophils.
    López-Osuna M; Arellano J; Kretschmer RR
    Parasite Immunol; 1992 Nov; 14(6):579-86. PubMed ID: 1470477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destruction of normal human eosinophils by Entamoeba histolytica.
    López-Osuna M; Kretschmer RR
    Parasite Immunol; 1989 Jul; 11(4):403-11. PubMed ID: 2550874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes.
    Rico G; Díaz-Guerra O; Giménez-Scherer JA; Kretschmer RR
    Arch Med Res; 1992; 23(2):157-9. PubMed ID: 1340282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage colony-stimulating factor enhances the respiratory burst of human monocytes in response to Entamoeba histolytica.
    García Lloret MI; Rocha Ramírez LM; Ramírez A; Santos Preciado JI
    Arch Med Res; 1992; 23(2):139-41. PubMed ID: 1340277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil and neutrophil chemiluminescence in patients with atopic asthma and in healthy subjects.
    Górski F; Krakowiak A; Ruta U; Pazdrak K; Palczynski C
    Allergol Immunopathol (Madr); 1993; 21(2):71-4. PubMed ID: 8393267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in research on virulence factors of Entamoeba histolytica].
    Chen Y; Cheng XJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Dec; 24(6):457-60. PubMed ID: 17366980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4.
    Munoz NM; Vita AJ; Neeley SP; McAllister K; Spaethe SM; White SR; Leff AR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):139-43. PubMed ID: 8301549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Entamoeba histolytica: II. Effect of humoral immune mechanisms on cytotoxic activity].
    Hudler H; Scheiner O; Stemberger H; Kollaritsch H; Wiedermann G
    Tropenmed Parasitol; 1984 Mar; 35(1):5-8. PubMed ID: 6324430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R; Jarillo-Luna A
    Parasite Immunol; 2005; 27(1-2):1-8. PubMed ID: 15813717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence.
    Davis PH; Zhang X; Guo J; Townsend RR; Stanley SL
    Mol Microbiol; 2006 Sep; 61(6):1523-32. PubMed ID: 16968225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunization in hamsters with live Entamoeba histolytica trophozoites of low virulence.
    Tsutsumi V; Shibayama-Salas M; Campos-Rodríguez R; Pacheco-Yépez J; Martínez-Palomo A
    Arch Med Res; 1992; 23(2):161-3. PubMed ID: 1340283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entamoeba histolytica: mechanism of decrease of virulence of axenic cultures maintained for prolonged periods.
    Olivos A; Ramos E; Nequiz M; Barba C; Tello E; Castañón G; González A; Martínez RD; Montfort I; Pérez-Tamayo R
    Exp Parasitol; 2005 Jul; 110(3):309-12. PubMed ID: 15955329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of N-acetylcysteine on the functional responses of human eosinophils in vitro.
    Martinez-Losa M; Cortijo J; Juan G; O'Connor JE; Sanz MJ; Santangelo F; Morcillo EJ
    Clin Exp Allergy; 2007 May; 37(5):714-22. PubMed ID: 17456219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
    Gutiérrez-Kobeh L; Cabrera N; Pérez-Montfort R
    J Parasitol; 1997 Apr; 83(2):234-41. PubMed ID: 9105303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entamoeba histolytica: differences in phagosome acidification and degradation between attenuated and virulent strains.
    Mitra BN; Kobayashi S; Saito-Nakano Y; Nozaki T
    Exp Parasitol; 2006 Sep; 114(1):57-61. PubMed ID: 16546173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.
    Tomioka K; MacGlashan DW; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1993 Nov; 151(9):4989-97. PubMed ID: 8409452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on a cytotoxin/enterotoxin from Entamoeba histolytica.
    Lushbaugh WB; Kairalla AB; Hofbauer AF; Cantey JR; Pittman FE
    Arch Invest Med (Mex); 1980; 11(1 Suppl):129-33. PubMed ID: 6258506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional upregulation of genes related to virulence activation in Entamoeba histolytica.
    Balderas-Renteria I; García-Lázaro JF; Carranza-Rosales P; Morales-Ramos LH; Galan-Wong LJ; Muñoz-Espinosa LE
    Arch Med Res; 2007 May; 38(4):372-9. PubMed ID: 17416282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of human Entamoeba histolytica infection by zymodeme, indirect hemagglutination and electroimmunotransfer blot assays.
    Sánchez-Guillén MC; Argüello-García R; Garduño G; Valadez-Salazar A; Martínez-García MC; Muñoz O; Ortega-Pierres MG
    Arch Invest Med (Mex); 1990; 21 Suppl 1():209-15. PubMed ID: 2136487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.